NasdaqGM - Delayed Quote USD
Actuate Therapeutics, Inc. Common stock (ACTU)
10.98
+0.38
+(3.58%)
At close: May 21 at 4:00:01 PM EDT
10.98
0.00
(0.00%)
After hours: May 21 at 4:04:13 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BIOS EQUITY COF, LP Beneficial Owner of more than 10% of a Class of Security | Purchase | Aug 14, 2024 | -- |
| THOMSON TODD S. Director and Beneficial Owner of more than 10% of a Class of Security | Sale | Aug 14, 2024 | -- |
Related Tickers
RNTX Rein Therapeutics Inc.
1.9400
+0.52%
CUE Cue Biopharma, Inc.
0.6012
-10.22%
COYA Coya Therapeutics, Inc.
5.67
-3.24%
APTOF Aptose Biosciences Inc.
1.6800
-5.62%
INAB IN8bio, Inc.
0.1260
-3.08%
APS.TO Aptose Biosciences Inc.
2.4000
+1.27%
GANX Gain Therapeutics, Inc.
1.8100
-5.24%
SRZN Surrozen, Inc.
7.31
-10.20%
12X1.DU Anavex Life Sciences Corp
6.73
+4.11%
PCJ.SG Abeona Therapeutics Inc
5.60
-0.88%